Valérie Cailleton

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

Ségolène Duran, Marianne Savès, Bruno Spire et al. · AIDS · 2001 · 278 citations

Public Health, Pharmacotherapy, Clinical Epidemiology +16

Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART

Ségolène Duran, Bruno Spire, François Raffi et al. · HIV Clinical Trials · 2001 · 219 citations · Full text

Public Health, Pharmacotherapy, Clinical Pharmacology +16

The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort

Patrizia Carrieri, Valérie Cailleton, Vincent Le Moing et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 184 citations

Public Health, Infectious Diseases, Clinical Pharmacology +16

Predictors of Long‐Term Increase in CD4⁺Cell Counts in Human Immunodeficiency Virus–Infected Patients Receiving a Protease Inhibitor–Containing Antiretroviral Regimen

Vincent Le Moing, Rodolphe Thiébaut, Geneviève Chêne et al. · The Journal of Infectious Diseases · 2002 · 112 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +15

Impact of Early versus Late Adherence to Highly Active Antiretroviral Therapy on Immuno-Virological Response: A 3-Year Follow-Up Study

Patrizia Carrieri, François Raffi, Charlotte Lewden et al. · Antiviral Therapy · 2003 · 93 citations · Full text

Public Health, Immunology, Infectious Diseases +17